Research compound reference
Informational pages on peptides and compounds commonly encountered in metabolic, recovery, and longevity research. Each entry covers mechanism of action, published research context, and regulatory status. None of this content constitutes medical advice.
Research use only. The compounds discussed here include approved medications, investigational drugs, and research peptides. Material sold as a research chemical is intended strictly for laboratory use and is not cleared for human administration. This page is not medical advice. Consult a qualified healthcare provider about any treatment decisions.
GLP-1 & Metabolic
Semaglutide
Long-acting GLP-1 receptor agonist originally developed by Novo Nordisk.
Also: GLP-1, Ozempic, Wegovy
Tirzepatide
First-in-class dual GIP and GLP-1 receptor agonist developed by Eli Lilly.
Also: GLP-1/GIP, Mounjaro, Zepbound
Retatrutide
Investigational triple agonist of GLP-1, GIP, and glucagon receptors.
Also: LY3437943, GGG tri-agonist
Cagrilintide
Long-acting amylin receptor analog in clinical development by Novo Nordisk.
Also: AM833, long-acting amylin analog
CagriSema
Investigational combination of a long-acting amylin analog and semaglutide.
Also: Cagrilintide and semaglutide, Cagri/Sema
Healing & Recovery
Growth Hormone Axis
Ipamorelin
Selective growth hormone secretagogue that acts at the ghrelin receptor.
Also: NNC 26-0161
Tesamorelin
Stabilized growth hormone-releasing hormone analog approved for HIV lipodystrophy.
Also: Egrifta, TH9507
IGF-1 LR3
Engineered insulin-like growth factor 1 variant with extended half-life.
Also: Long R3 IGF-1, Long Arg3 IGF-1
Immune & Longevity
Melanocortin
Research Support
*These statements have not been evaluated by the Food and Drug Administration. The compounds discussed on this site are not intended to diagnose, treat, cure, or prevent any disease. Content is for educational and research purposes only and is not a substitute for professional medical advice. Material sold by third parties as research chemicals is not cleared for human administration. Always consult your healthcare provider before starting any medication or treatment regimen.